In April 2011, eighty-five physicians and scientists gathered in Bethesda, Maryland to exchange the latest discoveries about chordoma and build partnerships with colleagues from across the world. Researchers came from thirty-one institutions in nine different countries, including – for the first time – four different pharmaceutical companies. At the workshop thirty-two speakers, including six Chordoma Foundation grant recipients, presented new, unpublished data spanning the gamut from epidemiology to genomics to clinical trials.